A renaissance for the contact system in blood coagulation?

Thrombosis and Haemostasis

Volumn 99, Issue 3, 2008, Pages 457-460

  Blat, Yuval ^a   Seiffert, Dietmar ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11;

BLEEDING; BLOOD CLOTTING; EDITORIAL; HUMAN; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; VASODILATATION;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FACTOR XI DEFICIENCY; FACTOR XIA; FACTOR XIIA; FEEDBACK, BIOCHEMICAL; GENOTYPE; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; PHENOTYPE; PLASMA KALLIKREIN; PREKALLIKREIN;

EID: 42249105219     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-11-0692     Document Type: Editorial

References (33)

1. Colman RW. Contact activation pathway: Inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities. In: Haemostasis and thrombosis. Lippincott Williams & Wilkins, Philadelphia; 2001: 104-121.
2. Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 2005; 86: 159-208.
3. Shariat-Madar Z, Schmaier AH. The plasma kallikrein/ kinin and renin angiotensin systems in blood pressure regulation in sepsis. J Endotoxin Res 2004; 10: 3-13.
4. Renne T, Gailani D. Role of Factor XII in haemostasis and thrombosis: clinical implications. Expert Rev Cardiovasc Ther 2007; 5: 733-741.
5. Iwaki T, Castellino FJ. Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost 2006; 95: 1003-1010.
6. Minnema MC, ten Cate H, Hack EC. The role of factor XI in coagulation: A matter of revision. Semin Thromb Haemost 1999; 25: 419-428.
7. Walsh PN. Factor XI. In: Haemostasis and Thrombosis. Lippincott Williams & Wilkins, Philadelphia; 2001: 191-202.
8. Gailani D, Broze GJJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912.
9. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. J Biol Chem 1991; 266: 7353-7358.
10. Brunnee T, La Porta C, Reddigari SR, et al. Activation of factor XI in plasma is dependent on factor XII. Blood 1993; 81: 580-586.
11. Scott CF, Colman RW. Fibrinogen blocks the autoactivation and thrombin-mediated activation of thrombin on dextran sulfate. Proc Natl Acad Sci USA 1992; 89: 11189-1193.
12. Bouma BN, Mosiner LO, Meijers JCM, et al. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation. Thromb Haemost 1999; 82: 1703-1708.
13. He R, Xiong S, He X, et al. The role of factor XI In a dilute thromboplastin assay of extrinsic coagulation pathway. Thromb Haemost 2001; 85: 1055-1059.
14. Keularts IMLW, Zivelin A, Seligsohn U, et al. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85: 1060-1065.
15. von dem Borne PA, Bajzar L, Meijers JC, et al. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 1997; 99: 2323-2327.
16. von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-3042.
17. Baglia FA, Walsh PN. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor-XI activation by thrombin. Biochemistry 1998; 37: 2271-2281.
18. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem 2000; 275: 20514-20519.
19. Oliver JA, Monroe DM, Roberts HR, et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1998; 19: 170-177.
20. Gailani D, Lasky NM, Broze GJ, Jr. A murine model of factor XI deficiency. Blood Coagul Fibrinolysis 1997; 8: 134-144.
21. Renne T, Pozgajova M, Gruner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281.
22. Wang X, Cheng Q, Xu L, et al. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 2005; 3: 695-702.
23. Kleinschnitz C, Stoll G, Bendszus M, et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with haemostasis. J Exp Med 2006; 203: 513-518.
24. Colman RW. Are haemostasis and thrombosis two sides of the same coin? J Exp Med 2006; 203: 493-495.
25. Pedicord DL, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci USA 2007; 104: 12855-12860.
26. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. . J Biol Chem 2000; 275: 20514-20519. Retraction in: J Biol Chem 2007; 282: 29067.
27. Baglia FA, Walsh PN. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor-XI activation by thrombin. Biochemistry 2007; 46: 12886-12887.
28. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388-6393.
29. Smith SA, Mutch NJ, Baskar D, et al. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-908.
30. Ruiz FA, Lea CR, Oldfield E, et al. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 2004; 279: 44250-44257.
31. Brush PJ, Anderson PH, Gunning RF. Identification of factor XI deficiency in Holstein-Friesian cattle in Britain. Vet Rec 1987; 121: 14-17.
32. Smith D, Gilbert M, Owen WG. Tissue plasminogen activator release in vivo in response to vaso-active agents. Blood 1985; 66: 835-839.
33. Hasan AA, Amenta S, Schmaier AH. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation. Circulation 1996; 94: 517-528.